RxNorm Names
EQUALINE CLEARLAX
(polyethylene glycol 3350)
powder, for solution
[Supervalu Inc]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0871542-9136-4cf8-a4b7-6c2b6edcbe0e| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | Abbreviated New Drug Application |
Uses
- •
- relieves occasional constipation (irregularity)
- •
- generally produces a bowel movement in 1 to 3 days
Warnings
Allergy alert: Do not use if you are allergic to polyethylene glycol
Ask a doctor before use if you have
- •
- nausea, vomiting or abdominal pain
- •
- a sudden change in bowel habits that lasts over 2 weeks
- •
- irritable bowel syndrome
Directions
- •
- do not take more than directed unless advised by your doctor
- •
- the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap)
- •
- adults and children 17 years of age and older:
- •
- fill to top of white section in cap which is marked to indicate the correct dose (17 g)
- •
- stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
- •
- use once a day
- •
- use no more than 7 days
- •
- children 16 years of age or under: ask a doctor
Other information
- •
- store at 20°-25°C (68°-77°F)
- •
- tamper-evident: do not use if printed foil seal under cap is missing, open or broken
Principal Display Panel
compare to MiraLAX® active ingredient
to-go pouches
travel size
original prescription strength
clearlax®
polyethylene glycol 3350
powder for solution
osmotic laxative
relieves occasional constipation (irregularity)
softens stool
# once-daily doses {Replace "#" with the number of Once-Daily Doses for the size}
| EQUALINE CLEARLAX
polyethylene glycol 3350 powder, for solution |
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
| Labeler - Supervalu Inc (006961411) |
Revised: 09/2012
Document Id: 5933e0bf-cf3b-4c04-b87c-82cc495b2a01
Set id: e0871542-9136-4cf8-a4b7-6c2b6edcbe0e
Version: 3
Effective Time: 20120927
Supervalu Inc
Review RxNorm Normal Forms
